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Despite the continued endemicity of Loa loa and Mansonella perstans infections in many parts of 
Nigeria, there has been no meaningful large-scale control program against them. This paper presents 
the epidemiological status of the infections in Nigeria, evaluates and emphasizes the severity of the 
recorded clinical symptoms, justifies the need for a control program, and proffers possible control 
measures. It is shown that, based on available literature, the clinical symptoms of the infections could 
be seriously debilitating with grave negative socio-economic impacts, especially among the rural 
populace who contribute immensely to agriculture in Nigeria. We opined that it is inhumane and 
deceptive to neglect these infectious diseases and the sufferers if truly the country desires health for 
all.   
 





Loa loa and Mansonella perstans are two important 
human filarial parasites which are found in tropical Africa, 
causing the diseases called loiasis and mansonellosis 
(perstans filariasis), respectively. Other human filarial 
parasites found in tropical Africa are Wuchereria 
bancrofti, Onchocerca volvulus, and Mansonella 
streptocerca (Hawking, 1977; Cheesbrough, 1987; 
Heyneman, 2004).  
L. loa infection is restricted to the rain-forest belt of 
western and central Africa and equatorial Sudan, and 
from 20 to 40 million has been estimated as carriers 
(Fain, 1978; Piekarski, 1989; Boussinesq and Gardon, 
1997). The two main vectors of human L. loa are 
Chrysops silacea and C. dimidiata which are normally 
restricted to the forest canopy (Fain, 1978; Noireau et al., 
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enhanced by human movement in the forest and the 
presence of wood-fire (Duke, 1955; Muirhead-Thomson, 
1982). M. perstans infection occurs across the centre of 
Africa, from Senegal and Gambia on the west coast to 
Kenya, Zimbabwe and Tanzania on the east (Piekarski, 
1989; Ottesen, 1990). The vectors are blood-sucking 
midges such as Culicoides grahamii, C. austeni, and C. 
fulvithorax which thrive in the underbrush (Crewe, 1977; 
Muirhead-Thomson, 1982; Agbolade, 2002).  
To the best of our knowledge, there has been no 
meaningful large-scale control program against L .loa and 
M. perstans infections in Nigeria or any other tropical 
African country despite the widespread distribution of the 
infections. This apparent neglect seems to be on the 
premise that the filarial infections, especially M. perstans, 
exhibit little or no severe symptoms. The situation is 
worsened by the common perception that the 
transmission of the infections is naturally controllable 
without any direct human efforts:  L. loa controlled by 
normal village growth and M. perstans by bush-burning.  





status of the infections in Nigeria since about three 
decades ago, re-appraises the recorded clinical 
symptoms of the infections, justifies the need for a control 
program, and proffers possible control measures against 





Evidences abound in literature that human L. loa infection 
has been recorded in Nigeria since, at least, four 
decades ago (Hawking, 1977) and that both L. loa and M. 
perstans infections have persisted in various parts of the 
country, especially in the rural areas. In the western part 
of Nigeria, Ogunba (1971) reported L. loa microfilaraemia 
prevalence of up to 11%, while the symptoms ranged 
from 15 to 61% among school children in Ijebu division. 
Ogunba (1972) studied L. loa distribution in all the 
vegetational zones of the defunct Western State of 
Nigeria and reported that in the rain-forest zone the 
prevalence of L. loa among school children ranged from 
0.9% in Ibadan division to 11.3% in Ilesha /Ife division. In 
the savannah zone the prevalence ranged from 0% in 
Egba, Ibadan and Owo divisions to 1% in Oyo division. 
The mangrove zone had 2.5% and 2.1% prevalence in 
Egbado and Okitipupa divisions, respectively. Among 
adults, the overall prevalence in the defunct State was 
found to be 8.3%. In a study among school children in 
Lagos State, Ejezie (1981) reported 0.7% prevalence of 
M. perstans. In a study at the University College Hospital, 
Ibadan, Akinboye and Ogunrinade (1987) reported a L. 
loa prevalence of 3.5% among blood donors. In another 
hospital-based study in metropolitan Lagos, Oyerinde et 
al. (1988) reported 5% and 0.8% prevalence of L. loa and 
M. perstans microfilaraemia, respectively. Three decades 
after Ogunba’s first report of L. loa from Ijebu division, 
Agbolade and Akinboye (2001) reported 10.5% and 3.2% 
prevalence of L. loa and M. perstans, respectively.  
In the eastern part of Nigeria, Arene and Atu (1986) 
reported 47% prevalence of M. perstans from Bori Local 
Government area of the Niger Delta. In another study in 
Niger Delta area, Udonsi (1986) reported 2.5% and 6% 
prevalence of L. loa and M. perstans, respectively. In the 
Igwun River Basin, Udonsi (1988) also reported 
prevalence values of 9.1% and 13.4% for L. loa and M. 
perstans, respectively. Recently, Takougang et al. (2002) 
reported up to 18% prevalence of L. loa from certain 
parts of Cross River State. Similarly, Anosike et al. (2004) 
reported L. loa and M. perstans as part of the 14 parasitic 
infections recorded among nomadic Fulanis of south-
eastern Nigeria.  
In the central part of Nigeria, Ufomadu et al. (1986) 
recorded 5.5% and 4.5% prevalence of L. loa and M. 
perstans, respectively. In another study in the area, 
Ufomadu et al. (1991) reported 2.1% and 6.8% 
prevalence of L. loa and M. perstans, respectively. In the 
same region, Akogun (1992) reported between 0.9% and  




5.2% prevalences of Loa loa among some rural populace 
of Mutum-Biyu district of Gongola State.   
In the northern part of Nigeria, Wijeyaratne et al. (1982) 
carried out a filariasis survey in Malumfashi district and 
reported M. perstans prevalence of 14.6% and 7.1% 
double infections with M. perstans and W. bancrofti. The 
authors also noted the presence of Chrysops vectors of 
L. loa in the district. In the north-western zone of Bauchi 
State, Anosike (1994) reported 0.7% and 1.4% 
prevalence of L. loa and M. perstans, respectively. In 
another study in Bauchi State, Anosike and Onwuliri 
(1994) reported 0.2% and 1.6% prevalence, respectively. 
The two studies from Bauchi State showed that 
fishermen, farmers and nomads were most affected.  
From the available reports, L. loa and M. perstans 
infections often co-exist in many parts of Nigeria, even 
with some subjects having double infections (Oyerinde et 
al., 1988; Udonsi, 1986, 1988; Ufomadu et al., 1986, 
1991; Anosike, 1994; Agbolade and Akinboye, 2001). 
The prevalences of L. loa and M. perstans 
microfilaraemia tend to increase with age and to be 
higher in males than in females in all parts of Nigeria 
(Ogunba, 1971; Oyerinde et al., 1988; Udonsi, 1988; 
Anosike, 1994). However, both infections occur 
indiscriminately in subjects regardless of their ABO blood 




CLINICAL SYMPTOMS  
 
Among local or permanent residents  of endemic regions, 
loiasis may be manifested only by an asymptomatic 
microfilaraemia in some infected subjects. But in many 
infected subjects, the adult worms sometimes move 
subconjunctivally across the eye (eye worm) (Nutman et 
al., 1986) often eliciting severe eye and peri-orbital 
itching and discomfort (Cook, 1990; Agbolade, 2002). In 
the Calabar area, up to 45% of the inhabitants of some 
localities were reported to experience eye worm which 
lasted 1 – 7 days (Takougang et al., 2002). In Nigeria, 
there have been two cases of total blindness due to 
intraocular adult L. loa worm infection (Osuntokun and 
Olurin, 1975). The commonest clinical symptom of loiasis 
is the fugitive swelling known as Calabar swellings which 
are localized areas of erythema and angioedema 
developing predominantly on the extremities 
(Cheesbrough, 1987; WHO, 1987; Ottesen, 1990). 
Takougang et al., (2002) reported 51% frequency of 
occurrence of Calabar swelling with 91% of the victims 
experiencing itching on the swellings. However, in Ijebu 
North area, eye and peri-orbital itching (associated with 
eye worm) and body itching (pruritus) were found more 
frequent in L. loa microfilaraemic subjects than Calabar 
swellings (Agbolade, 2002). In some few cases, loiasis 
has also been associated with some serious disorders 
including nephropathy,  cardiomyopathy  and  encephalo- 




pathy (Ottesen, 1990; Chippaux et al., 1996).  
As stated above, M. perstans is generally regarded as 
asymptomatic because in some regions up to 90% of 
infected native subjects may exhibit little or no clinical 
manifestations. However, is it humane to neglect the  
10% of the infected subjects who suffer serious 
symptoms of the infection? Serious symptoms that have 
been reported in mansonellosis include pruritus; 
swellings (similar to Calabar swellings); fever; pain in 
bursae and/or joint synovia, in serous cavities, or in the 
liver region; elephantoid scrotum; extreme exhaustion; 
and psychological symptoms (Adolph et al., 1962; Arene 
and Atu, 1986; Piekarski, 1989; Ottesen, 1990; Agbolade 
and Akinboye, 2005a). 
Both L. loa and M. perstans infections elicit eosinophilia 
in sufferers like many other infectious diseases (Ottesen, 
1990). However, there seems to be an additional 
haematological picture in some Nigerians infected with L. 
loa and/or M. perstans who had marked monocytosis (an 
increase in monocyte count above the normal or 
reference range) and neutrophilic toxic granulations 
(Agbolade, 2002, Agbolade and Akinboye, 2005a). It is 
known that monocytosis may occur in parasitic infections 
(Baker et al., 1998) and it has been documented that 
monocytes are involved in inflammatory response (Ward, 
1980; Guyton and Hall, 1996), while neutrophilic toxic 
granulations are naturally associated with severe, 
particularly bacterial, infections (Dacie and Lewis, 1984). 
The occurrence of monocytosis and neutrophilic toxic 
granulations in loiasis and mansonellosis patients further 
demonstrates the seriousness of the infectious diseases.  
In both L. loa and M. perstans infections, most of the 
clinical symptoms earlier stated in this review (especially 
pruritus and eosinophilia) are more frequent and 
debilitating in visitors who enter endemic regions 
(Nutman et al., 1986).    
 
 
JUSTIFICATION OF THE NEED FOR CONTROL 
 
Human loiasis is important socio-economically because 
of the appreciable morbidity it causes, particularly in the 
rural areas (Hovette et al., 1994), and also because it 
selectively affects man in the prime of life (Fain, 1978). 
According to Boulestiex and Carme (1986) and Pinder 
(1988), L. loa infection represents the third commonest 
cause for medical consultation in rural areas of some 
endemic countries. Should not this give health planners a 
serious concern? In Ijebu North area of western Nigeria, 
10.3% of school children and adults infected with L. loa 
claimed inability to study or work during clinical 
symptoms episodes (Agbolade, 2002). Similarly, the 
socio-economic impact of M. perstans is demonstrated by 
the observation that 16.7% of infected school children 
and adults in Ijebu North  area  of  western  Nigeria  were 
unable to study or work during the peak of clinical unable 





episodes (Agbolade, 2002; Agbolade and Akinboye, 
2005a). Since the clinical symptoms in both L. loa and M. 
perstans infections are recurrent, the economic loses due 
the infections will no doubt be enormous.  
The relatively recent reports of both L. loa and M. 
perstans infections from different parts of Nigeria stated 
earlier in this review (Agbolade and Akinboye, 2001; 
Takougang et al., 2002; Anosike et al., 2004) and some 
other related ones (Agbolade and Akinboye, 2005b) 
indicate that transmission of the infections in recent years 
cannot be ruled out. Some recent vector studies in Ijebu 
North area of western Nigeria have shown continued 
presence of the vectors and, in some cases, L3 infections 
in the vectors (Agbolade and Akinboye, 2001; Agbolade, 
2002; Agbolade et al., under review). This is noteworthy 
because forest destruction and bush-burning have 
always occurred in the area. Possibly the widespread 
occurrence of flood due to rising sea level has provided 
new breeding sites for the vectors.  
It is also pertinent to emphasize that many that ‘live’ 
with the insect vectors are ignorant of their potential roles 
in the transmission of parasitic diseases (Agbolade, 
personal observation). The situation is worsened by the 
fact that many rural health workers are ignorant of the 
aetiology and symptoms of both L. loa and M. perstans 
infections. Were they taught at health school at all? 
Ignorance has been identified one of the important 
factors enhancing the continued endemicity of parasitic 
infection in tropical African countries (Ukoli, 1984, 1992).  
Without a concerted control program how can the rural 
dweller be adequately informed?   
It is well known that Nigeria and other African countries 
rely mainly on the rural populace for food production and 
agriculture in general (Ukoli, 1992). Yet, the rural dwellers 
who suffer from loiasis and mansonellosis, in addition to 
some other diseases, are been neglected simply because 
L. loa and M. perstans infections are ‘less serious 
diseases’. It is our opinion that there is a need for a 
change for the better if health for all is truly desired and 
targeted.   
 
 
POSSIBLE CONTROL MEASURES 
 
The control of both L. loa and M. perstans infections can 
easily go together because they often co-exist. 
Fortunately, the drug of choice for both infections is 
diethylcarbamazine (DEC) which is usually administered 
at a dosage of 8-10 mg/kg/day for 2-3 weeks (for 
microfilaraemic loiasis) and 5-6 mg/kg/day for 10-20 days 
(for microfilaraemic mansonellosis). To avoid severe 
adverse effects (complications) in patients with high 
microfilaraemic intensity, low doses of DEC are given at 
initial days, and in loiasis, with simultaneous 
administration  of  steroids   (Cook, 1990; Ottesen, 1990).  
The microfilarial intensities of both infections appear 





mass chemotherapy with DEC will be safe in many 
cases. When necessary, the intensities (microfilarial 
loads) of the infections in victims can be determined 
using counting chamber method which is easy, time-
saving, highly quantitative and cost-effective (WHO, 
1987; Agbolade and Akinboye, 2005b).  
Ivermectin (IVM), which is commonly used in 
onchocerciasis control, is essentially effective only in 
treating amicrofilaraemic loiasis (Hovette et al., 1994). 
However, it has been found that a single annual dose can 
markedly reduce loiasis transmission (Duong et al., 
1997). This implies that with little, but concerted, 
additional measures, loiasis (and mansonellosis) can be 
meaningfully controlled in regions where IVM distribution 
is in effect.  
Chemical control of the vectors can be done by 
larvicide spraying of the muddy areas which serve as 
breeding sites of the vectors in endemic regions. Dieldrin 
has been found effective against Chrysops in some 
limited trials (WHO, 1984). Siting of residential houses 
and schools away from banana plantations, wearing of 
protective clothing and application of insect-repellent 
creams to the body of inhabitants of endemic areas will 
hinder or reduce human-vectors contact.  
However, only little can be achieved without a drastic 
effort to strip the rural dwellers of their ignorance of these 
infectious diseases. Therefore, there is need to 
adequately and consistently educate the rural populace 
on their aetiology, transmission and possible control 
measures. This is achievable through the rural health 
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